Microbes and microbial toxins: Paradigms for microbial-mucosal interactions V. Cholera: Invasion of the intestinal epithelial barrier by a stably folded protein toxin

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 5 43-5, 2001, Pages

  Lencer, Wayne I ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Caveolae; Endoplasmic reticulum associated degradation; Lipid rafts

Indexed keywords

CHOLERA TOXIN; GANGLIOSIDE GM1; LIPID; MEMBRANE RECEPTOR;

ARTICLE; CHOLERA; DIARRHEA; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; INTESTINE EPITHELIUM; INTESTINE MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; VIBRIO CHOLERAE;

EID: 0035026929     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.5.g781     Document Type: Article

References (27)

1. Anonymous. Cholera in 1994. Part I. Wkly Epidemiol Rec 70: 201-208, 1995.
2. M1. Am J Physiol Gastrointest Liver Physiol 278: G895-G904, 2000.
3. Brown D and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275: 17221-17224, 2000.
4. Hazes B and Read RJ. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 36: 11051-11054, 1997.
5. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, and White O. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406: 477-483, 2000.
6. Jackson ME, Simpson JC, Girod A, Pepperkok R, Roberts LM, and Lord JM. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J Cell Sci 112: 467-475, 1999.
7. Karaolis DK, Somara S, Maneval DR Jr, Johnson JA, and Kaper JB. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature 399: 375-379, 1999.
8. Lee SH, Hava DL, Waldor MK, and Camilli A. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99: 625-634, 1999.
9. Lencer WI, Constable C, Moe S, Jobling M, Webb HM, Ruston S, Madara JL, Hirst T, and Holmes R. Targeting of cholera toxin and E. coli heat labile toxin in polarized epithelia: role of C-terminal KDEL. J Cell Biol 131: 951-962, 1995.
10. Lencer WI, Hirst TR, and Holmes RK. Membrane traffic and the cellular uptake of cholera toxin. Biochim Biophys Acta Mol Cell Res 1450: 177-190, 1999.
11. Lencer WI, Moe S, Rufo PA, and Madara JL. Transcytosis of cholera toxin subunits across model human intestinal epithelia. Proc Natl Acad Sci USA 92: 10094-10098, 1995.
12. Majoul I, Sohn K, Wieland FT, Pepperkok R, Pizza M, Hillemann J, and Söling H-D. KDEL receptor (Erd2p)-mediated retrograde transport of the cholera toxin A subunit from Golgi involves COPI, p23, and the COOH terminus of Erd2p. J Cell Biol 143: 601-612, 1998.
13. Majoul IV, Bastiaens PIH, and Söling H-D. Transport of an external Lys-Asp-Glu-Leu (KDEL) protein from the plasma membrane to the endoplasmic reticulum: studies with cholera toxin in Vero cells. J Cell Biol 133: 777-789, 1996.
14. Mekalanos JJ, Collier RJ, and Romig WR. Enzymic activity of cholera toxin. II Relationships to proteolytic processing, disulfide bond reduction, and subunit composition. J Biol Chem 254: 5855-5861, 1979.
15. Mekalanos JJ and Sadoff JC. Cholera vaccines: fighting an ancient scourge. Science 265: 1387-1389, 1994.
16. Orlandi PA. Protein-disulfide isomerase-mediated reduction of the A subunit of cholera toxin in a human intestinal cell line. J Biol Chem 272: 4591-4599, 1997.
17. Orlandi PA and Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141: 905-915, 1998.
18. Plemper RK and Wolf DH. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biol Sci 24: 266-270, 1999.
19. Schmitz A, Herrgen H, Winkeler A, and Herzog V. Cholera toxin is exported from microsomes by the sec61p complex. J Cell Biol 148: 1203-1212, 2000.
20. Sixma TK, Pronk SE, Kalk HH, Wartna ES, van Zanten BAM, Witholt B, and Hol WGJ. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351: 371-377, 1991.
21. Sixma TK, Pronk SE, Kalk KH, van Zanten BAM, Berghuis AM, and Hol WGJ. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography. Nature 355: 561-564, 1992.
22. Taylor RK, Miller VL, Furlong DB, and Mekalanos JJ. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad USA 84: 2833-2837, 1987.
23. Tsai B, Rodighiero C, Lencer WI, and Rapoport T. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell. In press.
24. Waldor MK and Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272: 1910-1914, 1996.
25. Ward CL, Omura S, and Kopito RR. Degradation of CFTR by the ubiquitin-proteosome pathway. Cell 83: 121-127, 1995.
26. White J, Johannes L, Mallard F, Girod A, Grill S, Reinsch S, Keller P, Tzschaschel B, Echard A, Goud B, and Stelzer EH. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J Cell Biol 147: 743-760, 1999.
27. Wolf AA, Jobling MG, Wimer-Mackin S, Madara JL, Holmes RK, and Lencer WI. Ganglioside structure dictates signal transduction by cholera toxin in polarized epithelia and association with caveolae-like membrane domains. J Cell Biol 141: 917-927, 1998.